Page last updated: 2024-09-03

di-n-desethylamiodarone and N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide

di-n-desethylamiodarone has been researched along with N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide in 1 studies

Compound Research Comparison

Studies
(di-n-desethylamiodarone)
Trials
(di-n-desethylamiodarone)
Recent Studies (post-2010)
(di-n-desethylamiodarone)
Studies
(N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide)
Trials
(N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide)
Recent Studies (post-2010) (N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide)
703903

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Davidoff, AM; Rankovic, Z; Wang, Y; Wu, Q; Yang, J; Young, B1

Reviews

1 review(s) available for di-n-desethylamiodarone and N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide

ArticleYear
Recent Advances with KDM4 Inhibitors and Potential Applications.
    Journal of medicinal chemistry, 2022, 07-28, Volume: 65, Issue:14

    Topics: Enzyme Inhibitors; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Neoplasms

2022